Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019

By sjmartinez • June 29, 2024

Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri N, Yang JD, Chen VL, Kim D, Fallon MB, Diaz LA, Arab JP, Mantzoros CS, Noureddin M, Lazarus JV, Wijarnpreecha K. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019. Metabolism. 2024 Jun 26:155958. doi: 10.1016/j.metabol.2024.155958. Epub ahead of print. PMID: 38942169.

Tags: Cedars Sinai DoM, Digestive Diseases, Disparity, Epidemiology, Liver disease, MASLD, Metabolic syndrome, NAFLD, non-alcoholic fatty liver disease

Understanding the Link Between Patient Symptoms and Provider Goals for Mucosal Healing in IBD: Insights from the IBD Qorus Survey

Troia A, Harvey S, Wu A, Kiparizoska S, Weaver A, Oberai R, Melmed GY, Siegel CA, Singh S, Mattar MC. Understanding the Link Between Patient[...]

Artificial intelligence prediction of age from echocardiography as a marker for cardiovascular disease

Rawlani M, Ieki H, Binder C, Yuan V, Chiu IM, Bhatt A, Ebinger JE, Sahashi Y, Ambrosy AP, Usuku H, Tsujita K, Cheng P, Kwan[...]

Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis

Dolmat M, Lemes JBP, Johnson WT, Wilkinson EL, Yaksh TL, Bottini N, Shah NJ. Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model[...]